Literature DB >> 18680431

Association of matrix metalloproteinases-9 gene polymorphisms with genetic susceptibility to esophageal squamous cell carcinoma.

Jin Wu1, Lin Zhang, Hao Luo, Zhendong Zhu, Conghai Zhang, Yiping Hou.   

Abstract

Matrix metalloproteinases-9 (MMP-9) plays important roles in tumor invasion and metastasis by degrading extracellular matrix components. Variations in the DNA sequence in the MMP-9 gene may lead to altered MMP-9 production and/or activity, and so this may modulate an individual's susceptibility to esophageal squamous cell carcinoma (ESCC). To test this hypothesis, we investigated the association of the MMP-9 polymorphisms and their haplotypes with the risk of ESCC in a Chinese population. There were significant differences in the genotype and allele distribution of P574R polymorphism of the MMP-9 gene among cases and controls. The P574R GG genotypes were associated with a significantly increased risk of ESCC as compared with the CC genotypes (odds ratio [OR] = 4.08; 95% confidence interval [CI]: 1.58-10.52; p = 0.00). Compared with 279R-574P haplotype, 279R-574R (OR = 3.52; 95% CI: 1.99-6.25) and 279Q-574P (OR = 2.16; 95% CI: 1.07-4.35) haplotypes can increase the onset risk of ESCC statistically, but the role of 279R-574R haplotype is more obvious. MMP-9 P574R polymorphisms and P574R-R279Q haplotype are significantly associated with the risk of ESCC. Our study shows for the first time that MMP-9 gene P574R polymorphism may contribute to a genetic risk factor for ESCC in a Chinese population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680431     DOI: 10.1089/dna.2008.0732

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  10 in total

1.  MMP-9 polymorphisms are related to serum lipids levels but not associated with colorectal cancer susceptibility in Chinese population.

Authors:  Zhi-Hui Yang; Shi-Ning Li; Jin-Xing Liu; Qing-Xi Guo; Xing-Wang Sun
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

2.  Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.

Authors:  Alexandra Mj Langers; Hein W Verspaget; Daniel W Hommes; Cornelis Fm Sier
Journal:  World J Gastrointest Oncol       Date:  2011-06-15

3.  Gelatinase B (-1562C/T) polymorphism in tumor progression and invasion of breast cancer.

Authors:  P Chiranjeevi; K Mrudula Spurthi; N Santhoshi Rani; G Rajesh Kumar; T Mohini Aiyengar; M Saraswati; G Srilatha; G Kishore Kumar; Sudha Sinha; C Sanjeeva Kumari; B Nagarjuna Reddy; S Vishnupriya; H Surekha Rani
Journal:  Tumour Biol       Date:  2013-12-20

4.  Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.

Authors:  Huai Liu; Pei-Yu Huang; Lin-Quan Tang; Qiu-Yan Chen; Ying Zhang; Lu Zhang; Ling Guo; Dong-Hua Luo; Hao-Yuan Mo; Yan-Qun Xiang; Fang Qiu; Rui Sun; Ming-Yuan Chen; Yi-Jun Hua; Xing Lv; Lin Wang; Chong Zhao; Xiang Guo; Ka-Jia Cao; Chao-Nan Qian; Ming-Huang Hong; Hai-Qiang Mai
Journal:  Med Oncol       Date:  2013-08-18       Impact factor: 3.064

Review 5.  Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.

Authors:  Ajay Kumar Chaudhary; Mamta Singh; Alok C Bharti; Kamlesh Asotra; Shanthy Sundaram; Ravi Mehrotra
Journal:  J Biomed Sci       Date:  2010-02-15       Impact factor: 8.410

6.  Genetic Variants in MMP9 and TCF2 Contribute to Susceptibility to Lung Cancer.

Authors:  Jing-Zhe Sun; Xue-Xi Yang; Ni-Ya Hu; Xin Li; Fen-Xia Li; Ming Li
Journal:  Chin J Cancer Res       Date:  2011-09       Impact factor: 5.087

7.  MMP-1/PAR-1 signal transduction axis and its prognostic impact in esophageal squamous cell carcinoma.

Authors:  Hong-Hua Peng; Xi Zhang; Pei-Guo Cao
Journal:  Braz J Med Biol Res       Date:  2011-11-16       Impact factor: 2.590

8.  Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk.

Authors:  Xuan Guan; Xiang Wang; Hao Luo; Jing Wu; Xiao Zhang; Jin Wu
Journal:  Med Sci Monit       Date:  2014-11-13

9.  Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.

Authors:  Janusz K Rybakowski
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-31

10.  Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression.

Authors:  Antonietta Rosella Farina; Andrew Reay Mackay
Journal:  Cancers (Basel)       Date:  2014-01-27       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.